Showing results (1-10 of 267) with videos related to
Sort By:
Pageof 27
Kidney International|November 25, 2019
A new mouse model of anti-GBM disease sheds light on maternal transfer of alloantibodies in glomerular diseaseMarina Vivarelli, Francesco EmmaKidney International|January 5, 2019
Levamisole for children with nephrotic syndrome: new evidence for the use of an "old" drugMarina Vivarelli, Francesco EmmaSeminars in Thrombosis and Hemostasis|May 7, 2014
Treatment of C3 glomerulopathy with complement blockersMarina Vivarelli, Francesco EmmaPediatric Nephrology (Berlin, Germany)|March 5, 2021
Update on the treatment of steroid-sensitive nephrotic syndromeFederica Zotta, Marina Vivarelli, Francesco EmmaPediatric Nephrology (Berlin, Germany)|April 29, 2017
Immunology of idiopathic nephrotic syndromeManuela Colucci, Giorgia Corpetti, Francesco Emma, et al.Pediatric Nephrology (Berlin, Germany)|April 11, 2023
A pediatric case of IgA nephropathy benefitting from targeted release formulation-budesonideLuca Antonucci, Manuela Colucci, Francesco Emma, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 13, 2016
Minimal Change DiseaseMarina Vivarelli, Laura Massella, Barbara Ruggiero, et al.The Journal of Pediatrics|March 13, 2010
Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndromeMarina Vivarelli, Eleonora Moscaritolo, Aggelos Tsalkidis, et al.Pediatric Nephrology (Berlin, Germany)|July 19, 2023
A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistanceEster Conversano, Hanna Debiec, Manuela Colucci, et al.Pediatric Nephrology (Berlin, Germany)|November 26, 2022
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practiceLaura Lucchetti, Antonio Gatto, Alessandra Gianviti, et al.Pageof 27